Skip to content

Maia Mallevays

2 papers in the library · 1 citation · publishing 2026

Papers

Sort Most recent Most cited

Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward.

European Neuropsychopharmacology September 19, 2026 Maia Mallevays, Lucie Berkovitch

Classic psychedelics, including lysergic acid diethylamide (LSD), psilocybin, and dimethyltryptamine (DMT), have re-emerged as promising treatments for psychiatric conditions linked to suicidality. However, rare reports of increased suicidality potentially associated with psychedelic use have raised safety concerns. This article examines the complex relationship between psychedelics and...

Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study

medRxiv Preprint Server March 31, 2026 Maia Mallevays, Louise Fuet, Michel Danon et al. 1 citation preprint

Esketamine is a fast-acting antidepressant drug which induces acute psychoactive effects. The most frequent is a dissociative state which seems unrelated to therapeutic efficacy. Other esketamine-induced effects, including psychedelic-like mystical experiences, have been poorly studied in terms of phenomenology and frequency, and may carry specific therapeutic relevance. In this study, we...